Indicated for asthma and chronic obstructive pulmonary disease to manage airway inflammation and support breathing maintenance.
Mechanism of Action
Budesonide provides anti-inflammatory action by suppressing cytokine release. Formoterol acts as a long-acting beta-2 agonist, stimulating receptors to maintain smooth muscle relaxation for extended periods.
Route of Administration
Inhalation
Onset Time
15 minutes
Duration
12 hours
Contraindications
Status asthmaticus, Hypersensitivity to budesonide or formoterol, Severe milk protein allergy
Information related to Symbicort Powder is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.